Fluconazole Suppression Therapy Guidelines

Dosage Recommendations

The recommended dosage for long-term fluconazole suppression therapy is 200 mg daily, with duration typically ranging from 6-12 months depending on the underlying infection and immune status of the patient 1, 2, 3
For cryptococcal meningitis maintenance therapy, fluconazole 200 mg daily is the recommended suppressive dose 2, 4
For chronic suppression of oropharyngeal candidiasis in patients with recurrent infection, fluconazole 100 mg three times weekly is recommended 6
For recurrent vulvovaginal candidiasis, fluconazole 150 mg weekly for 6 months is the recommended suppressive regimen 7, 8
For coccidioidomycosis requiring long-term suppression, fluconazole 400 mg daily for 6-12 months is recommended 3

HIV patients with cryptococcal meningitis should receive a minimum of 12 months of fluconazole therapy, with consideration for discontinuation only after immune reconstitution (CD4 >100 cells/μL and undetectable viral load for ≥3 months) 2, 5
Transplant recipients with cryptococcosis should receive fluconazole 200-400 mg daily for 6-12 months 3
For patients with persistent immunosuppression, longer or indefinite suppression may be necessary 5
For non-meningeal cryptococcosis in immunocompetent patients with no risk factors, fluconazole 400 mg daily for 6-12 months is recommended 4, 3

Regular monitoring of liver function is recommended for prolonged therapy exceeding 21 days 5
For cryptococcal infections, monitor for clinical signs of relapse and consider antigen testing when available 3
Drug interactions with antiretroviral medications should be considered when determining dosage 5
Development of resistance is a concern with long-term fluconazole use, especially with prior azole exposure 5, 8
Premature discontinuation of suppressive therapy in HIV patients before adequate immune reconstitution can lead to relapse 2, 5

For cryptococcal infections, clinical and mycological response should guide treatment duration 3
Consider discontinuation only after resolution of all signs, symptoms, and laboratory abnormalities 4
In immunocompetent patients, 6-12 months of therapy is typically sufficient for most fungal infections 3